- info@cohortias.com
- Sitio en Español
- Careers
- Network
COVID-19 resources / Clinical Research Insights and News
The Cohortias Blog
Stay informed
COVID-19 resources
Cohortias is bringing clinical research to Latin America, now proud to participate in COVID-19 clinical trials.
Our archive includes insights from our experts as they discuss lessons learned over the past three months in managing COVID-19’s impact on trials in Latin America and around the world.
Our blog posts provide insights into what companies should be doing now to prepare for the upcoming ‘new normal’.
Clinical Research in Brazil | Cohortias the CRO of LATAM
Step into the world of clinical research in Brazil, a nation celebrated for its vibrant culture and its rising prominence in the global healthcare arena. ...
Clinical Research in Colombia | Cohortias the CRO of LATAM
Step into the world of clinical research in Colombia, a country known for its rich cultural heritage and growing prominence in the global healthcare landscape. ...
Clinical Research in Mexico | Cohortias the CRO of LATAM
Delve into the realm of clinical research in Mexico, a dynamic landscape where innovation and healthcare advancement converge. Cohortias, a leader in the field, is ...
Full Service CRO in Latin America | Cohortias the CRO of LATAM
Welcome to Cohortias, your trusted partner for comprehensive Clinical Research Organization (CRO) services in Latin America. As a full-service CRO, we offer a dynamic range ...
COVID-19 Research - Free Consultation
The clinical development journey is fraught with pitfalls and roadblocks; COVID-19 has almost overnight added to the complexity. Innovations, technologies and reinvented processes can help. Our experienced team of experts shares experiences, lessons learned and tips to help you mitigate risk in the current environment while implementing some of the industry’s latest innovations.
The presence of clinical research in Latin America has been growing steadily for the last decade, mainly because of cost effectiveness, excellent patient recruitment and the emergence of FDA approved regulatory agencies.
